Amgen Inc (AMGN)
NASDAQ · Healthcare · Drug Manufacturers - General
Amgen Inc is a Healthcare company with a market capitalization of $193.39B, a trailing P/E ratio of 24.9, and a dividend yield of 2.74%.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | April 30, 2026 | $5.15 | $4.77 | +8.0% |
| Q4 2025 | February 3, 2026 | $5.29 | $4.73 | +11.8% |
| Q3 2025 | November 4, 2025 | $5.64 | $5.01 | +12.6% |
| Q2 2025 | August 5, 2025 | $2.65 | $3.12 | -15.1% |
| Q1 2025 | May 1, 2025 | $4.90 | $4.26 | +15.0% |
| Q4 2024 | February 4, 2025 | $5.31 | $5.08 | +4.5% |
Other Drug Manufacturers - General Stocks
Frequently Asked Questions
What is Amgen Inc's market cap?
As of June 29, 2026, Amgen Inc (AMGN) has a market capitalization of $193.39B.
What is Amgen Inc's P/E ratio?
Amgen Inc trades at a trailing price-to-earnings (P/E) ratio of 24.9. Its forward P/E is 16.1.
Does Amgen Inc pay a dividend?
Yes — Amgen Inc pays a dividend yielding 2.74%, an annual payout of $9.66 per share.
What sector is AMGN in?
Amgen Inc is in the Healthcare sector, specifically the Drug Manufacturers - General industry.
What was Amgen Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), Amgen Inc reported revenue of $36.74B and net income of $7.71B.
Ask your own questions about AMGN
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.